Clinical Study

Fulvestrant Alone Versus Fulvestrant And Everolimus Versus Fulvestrant, Everolimus And Anastrozole: A Phase III Randomized Placebo-Controlled Trial I

Posted Date: May 15, 2019

  • Investigator: John Morris
  • Specialties:
  • Type of Study: Drug

The purpose of this study is to find out the good and/or bad effects of adding the drugs anastrozole and everolimus to regular treatment with fulvestrant. We will look at the effects on you and your disease. Anastrozole, everolimus and fulvestrant are all approved by the Food and Drug Administrati

Criteria:

To Be Eligible For This Study, Patients Must Be Postmenopausal And Have Breast Cancer That Has Sprea

Keywords:

Cancer, Stage 4, Breast, S1222, Hormone-Receptor Pos

For More Information:

Uc Cancer Institute
513-584-7698
kastla@ucmail.uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.